LJ
Lillie James Woodruff
OFFICERM
€932,119
▼ Sales (11 ops.)
Insider track record
OtherNot enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the detailed record of transactions filed by Lillie James Woodruff. Insider active across 1 company, notably MapLight Therapeutics, Inc.. Cumulatively, 15 filings have been published. Breakdown: 0 buy · 11 sells. Total volume traded: €932k. History available since 27 October 2025. The latest transaction was disclosed on 17 August 2026 (Attribution). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Lillie James Woodruff
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations15 total
7,730 shares0Voting Common StockSEC:0001728746-26-000016:0
22,082 shares@ US$12.540.047% mcap9.7% of flowVoting Common StockSEC:0001728746-26-000014:0
5,393 shares@ US$36.990.012% mcap8.7% of flowVoting Common StockSEC:0001728746-26-000012:1
12 shares@ US$37.540.0000% mcap0.0% of flowVoting Common StockSEC:0001728746-26-000012:2
5,009 shares@ US$36.450.011% mcap8.0% of flowVoting Common StockSEC:0001728746-26-000012:3
2,238 shares@ US$36.000.0047% mcap3.5% of flowVoting Common StockSEC:0001728746-26-000012:0
3,526 shares@ US$37.260.0076% mcap5.7% of flowVoting Common StockSEC:0001728746-26-000012:4
12 shares@ US$37.960.0000% mcap0.0% of flowVoting Common StockSEC:0001728746-26-000012:5
2,077 shares@ US$37.900.0046% mcap3.4% of flowVoting Common StockSEC:0001728746-26-000012:6
1,730 shares@ US$26.820.0028% mcap37.8% of flowVoting Common StockSEC:0001728746-26-000006:0
686 shares@ US$27.010.0011% mcap15.1% of flowVoting Common StockSEC:0001728746-26-000006:1
2,097 shares@ US$27.490.0035% mcap47.1% of flowVoting Common StockSEC:0001728746-26-000006:2
7,730 shares0Voting Common StockSEC:0001728746-26-000004:0
45,055 shares@ US$17.9886.8% of flowVoting Common StockSEC:0001728746-26-000002:0
32,539 shares0Voting Common StockSEC:0001728746-25-000007:0
About Lillie James Woodruff
Lillie James Woodruff is a declarant linked to MapLight Therapeutics, Inc., where the listed role is Chief Scientific Officer. Across 13 filings in total, the 13 sampled filings run from 2025-10-28 to 2026-07-17, with EUR 0 of buys and EUR 692039 of sells, and the most frequent transaction nature is sale.